Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Taru Hallinen"'
Autor:
Tarja Mälkönen, Pauliina Nuutinen, Taru Hallinen, Erkki Soini, Riikka Nissinen, Christina Wennerstöm, Tapio Rantanen, Johanna H. Hagman, Rauno Harvima, Johanna Höök-Nikanne, Tiina Ilves, Päivi Lintu, Ken Malanin, Iina Soramäki, Kaisa Tasanen, Arja Teho, Katja Vähävihu, Sari Itälinna, Pekka Leinonen, Piia Sarajärvi, Laura Huilaja, Rafael Pasternack
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Guselkumab treatment outcomes and persistence were assessed in a real-world cohort of Finnish patients with difficult-to-treat plaque psoriasis over a median follow-up of 1 year. Data on 181 patients who initiated guselkumab at the 15 study centres w
Externí odkaz:
https://doaj.org/article/823350c3b99f403a800589a20c0ee1ad
Taru Hallinen,1 Santtu Kivelä,1 Erkki Soini,1 Veli-Pekka Harjola,2 Mari Pesonen3 1ESiOR Oy, Kuopio, Finland; 2Emergency Medicine, University of Helsinki, Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finlan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24502817d057133e6a26d0641b30ccd0
http://hdl.handle.net/10138/354164
http://hdl.handle.net/10138/354164
Autor:
Erkki Soini, Pia Eloranta, Sari Sintonen, Mikko Kosunen, Miika Linna, C. Asseburg, Taru Hallinen
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Taru Hallinen,1 Erkki Soini,1 Christian Asseburg,1 Miika Linna,2 Pia Eloranta,3 Sari Sintonen,3 Mikko Kosunen3 1ESiOR Oy, Kuopio, Finland; 2Aalto University, Department of Industrial Engineering and Management, Espoo, Finland; 3Pfizer Oy, Helsinki, F
Autor:
Ritva Koskela, Clas-Göran af Björkesten, Jyrki Tillonen, Christian Nielsen, M Koivunen, Erkki Soini, Taru Hallinen, Ilkka Vihriälä, Airi Jussila, Ulla-Maija Suhonen, C Wennerström, Karri T Utriainen, Inka Koskinen, Kalle Hakala, R Nissinen, Tuire Ilus, Andras Borsi, Heikki Nuutinen, Markku Heikkinen, Veikko Moilanen, Taina Sipponen, Urpo Nieminen, Anja Eberl, Mikko Heikura
Publikováno v:
European Journal of Gastroenterology & Hepatology
Objective: Long-term evidence on ustekinumab treatment response and persistence in patients with Crohn’s disease in a real-world setting is scarce. We performed a retrospective nationwide chart review study of long-term clinical outcomes in Crohn
Autor:
Jyrki Tillonen, Ritva Koskela, M Koivunen, Ulla Maija Suhonen, Mikko Heikura, Christian Nielsen, Anja Eberl, Taru Hallinen, E Christina M Wennerström, Mikko Kellokumpu, Heikki Nuutinen, Markku Heikkinen, Erkki Soini, Tuire Ilus, Andras Borsi, Clas Göran af Björkesten, Taina Sipponen
Publikováno v:
Scandinavian journal of gastroenterology. 56(6)
Background: Real-world evidence to support optimal ustekinumab dosing for refractory Crohn’s disease (CD) patients remains limited. Data from a retrospective nationwide chart review study was utilized to explore ustekinumab dosing dynamics and opti
Autor:
H. Kemppainen, Pauliina Molander, Taru Hallinen, R Nissinen, V. Veckman, D. Naessens, Erkki Soini, C G af Björkesten, S. Valgardsson, P. Mankinen, Airi Jussila
Background and Aims: A retrospective non-interventional, multi-centre patient chart review study was conducted to investigate the association of faecal calprotectin (FC) 1 year (+/- 2 months) after biological therapy initiation with composite event-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88671530f16fb99e66ab3e4b836b60fd
http://hdl.handle.net/10138/319298
http://hdl.handle.net/10138/319298
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Erkki Soini,1 Ossi Riekkinen,2 Heikki Kröger,3,4 Petri Mankinen,1 Taru Hallinen,1 Janne P Karjalainen2 1ESiOR Oy, Kuopio, Finland; 2Bone Index, Kuopio, Finland; 3Kuopio Musculoskeletal Research Unit, University of Eastern Finland, Kuopio, Finland; 4
Autor:
Kalle Hakala, C Wennerström, Eija Hirsi, Moilanen, Mikko Heikura, Ilkka Vihriälä, Jyrki Tillonen, C G af Björkesten, Karri T Utriainen, Taru Hallinen, Urpo Nieminen, Heikki Nuutinen, Tuire Ilus, Ulla-Maija Suhonen, Erkki Soini, Ritva Koskela, Mikko Kellokumpu, Airi Jussila, Christian Nielsen, Anja Eberl, Inka Koskinen, Andras Borsi, R Nissinen, Taina Sipponen, Markku Heikkinen, M Koivunen
Publikováno v:
Journal of Crohn's and Colitis. 14:S434-S435
Background Real-life long-term evidence on ustekinumab treatment response in patients with Crohn’s disease (CD) is scarce. We performed a retrospective non-interventional nationwide chart review study of dosing and long-term clinical outcomes in Fi
Autor:
Taina Sipponen, Anja Eberl, Karri T Utriainen, Taru Hallinen, Ilkka Vihriälä, Jyrki Tillonen, Inka Koskinen, Andras Borsi, Christian Nielsen, Ulla-Maija Suhonen, Eija Hirsi, R Nissinen, C Wennerström, Heikki Nuutinen, M Koivunen, Mikko Kellokumpu, Clas-Göran af Björkesten, Erkki Soini, Markku Heikkinen, Veikko Moilanen
Background: Ustekinumab (UST), a human anti-IL12/23p40 monoclonal antibody, has been approved for treatment of Crohn?s Disease (CD) since the end of 2016. This nationwide noninterventional, retrospective chart review explored real-life data in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051170f4bddc4cdc187d73015a2d3579
http://hdl.handle.net/10138/306944
http://hdl.handle.net/10138/306944
Autor:
Ritva Koskela, Mikko Kellokumpu, Mikko Heikura, Taru Hallinen, Christian Nielsen, C Wennerström, Urpo Nieminen, M Koivunen, Inka Koskinen, Ilkka Vihriälä, C G af Björkesten, Kalle Hakala, Eija Hirsi, Anja Eberl, Erkki Soini, Jyrki Tillonen, R Nissinen, Ulla-Maija Suhonen, Taina Sipponen, Tuire Ilus, Veikko Moilanen, Andras Borsi, Heikki Nuutinen, Markku Heikkinen, Karri T Utriainen, Airi Jussila
Publikováno v:
Journal of Crohn's and Colitis. 14:S066-S066
Background Real-life long-term evidence on ustekinumab treatment in patients with Crohn’s disease (CD) is limited. We performed a retrospective non-interventional nation-wide chart review study of dosing and long-term clinical outcomes in Finnish C